ALKBH5 and pancreatic neoplasm: Mechanistically, ALKBH5 inhibited PER1-ATM-CHK2-P53/CDC25C signaling in an m6A-YTHDF2-dependent manner, and P53-induced ALKBH5 activation acted as a feedback loop modulating m6A modification in pancreatic cancer 22.